360 related articles for article (PubMed ID: 26027680)
1. Molecular Mechanisms of PPAR-γ Governing MSC Osteogenic and Adipogenic Differentiation.
Zhuang H; Zhang X; Zhu C; Tang X; Yu F; Shang GW; Cai X
Curr Stem Cell Res Ther; 2016; 11(3):255-64. PubMed ID: 26027680
[TBL] [Abstract][Full Text] [Related]
2. PPARγ and Wnt Signaling in Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells.
Yuan Z; Li Q; Luo S; Liu Z; Luo D; Zhang B; Zhang D; Rao P; Xiao J
Curr Stem Cell Res Ther; 2016; 11(3):216-25. PubMed ID: 25986621
[TBL] [Abstract][Full Text] [Related]
3. Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies.
Takada I; Kouzmenko AP; Kato S
Expert Opin Ther Targets; 2009 May; 13(5):593-603. PubMed ID: 19397478
[TBL] [Abstract][Full Text] [Related]
4. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
[TBL] [Abstract][Full Text] [Related]
5. Cross-Talking Between PPAR and WNT Signaling and its Regulation in Mesenchymal Stem Cell Differentiation.
Xu C; Wang J; Zhu T; Shen Y; Tang X; Fang L; Xu Y
Curr Stem Cell Res Ther; 2016; 11(3):247-54. PubMed ID: 26201865
[TBL] [Abstract][Full Text] [Related]
6. PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells.
Yu WH; Li FG; Chen XY; Li JT; Wu YH; Huang LH; Wang Z; Li P; Wang T; Lahn BT; Xiang AP
Int J Biochem Cell Biol; 2012 Feb; 44(2):377-84. PubMed ID: 22120652
[TBL] [Abstract][Full Text] [Related]
7. Interferon gamma inhibits adipogenesis in vitro and prevents marrow fat infiltration in oophorectomized mice.
Vidal C; Bermeo S; Li W; Huang D; Kremer R; Duque G
Stem Cells; 2012 May; 30(5):1042-8. PubMed ID: 22331815
[TBL] [Abstract][Full Text] [Related]
8. PPAR-γ and Wnt Regulate the Differentiation of MSCs into Adipocytes and Osteoblasts Respectively.
Li Y; Jin D; Xie W; Wen L; Chen W; Xu J; Ding J; Ren D
Curr Stem Cell Res Ther; 2018 Feb; 13(3):185-192. PubMed ID: 29034841
[TBL] [Abstract][Full Text] [Related]
9. The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations.
Hasegawa T; Oizumi K; Yoshiko Y; Tanne K; Maeda N; Aubin JE
BMC Dev Biol; 2008 Jul; 8():71. PubMed ID: 18625072
[TBL] [Abstract][Full Text] [Related]
10. Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs).
Martin PJ; Haren N; Ghali O; Clabaut A; Chauveau C; Hardouin P; Broux O
BMC Cell Biol; 2015 Mar; 16():10. PubMed ID: 25887582
[TBL] [Abstract][Full Text] [Related]
11. A novel PPARγ2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiation.
Kim J; Ko J
Cell Death Differ; 2014 Oct; 21(10):1642-55. PubMed ID: 24948012
[TBL] [Abstract][Full Text] [Related]
12. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis.
Casado-Díaz A; Santiago-Mora R; Dorado G; Quesada-Gómez JM
Osteoporos Int; 2013 May; 24(5):1647-61. PubMed ID: 23104199
[TBL] [Abstract][Full Text] [Related]
13. Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2.
Chen YH; Yeh FL; Yeh SP; Ma HT; Hung SC; Hung MC; Li LY
J Biol Chem; 2011 Mar; 286(12):10671-80. PubMed ID: 21247904
[TBL] [Abstract][Full Text] [Related]
14. β-catenin directly sequesters adipocytic and insulin sensitizing activities but not osteoblastic activity of PPARγ2 in marrow mesenchymal stem cells.
Rahman S; Czernik PJ; Lu Y; Lecka-Czernik B
PLoS One; 2012; 7(12):e51746. PubMed ID: 23272157
[TBL] [Abstract][Full Text] [Related]
15. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells.
Muruganandan S; Roman AA; Sinal CJ
J Bone Miner Res; 2010 Feb; 25(2):222-34. PubMed ID: 19929432
[TBL] [Abstract][Full Text] [Related]
16. S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis.
Cao Y; Gomes SA; Rangel EB; Paulino EC; Fonseca TL; Li J; Teixeira MB; Gouveia CH; Bianco AC; Kapiloff MS; Balkan W; Hare JM
J Clin Invest; 2015 Apr; 125(4):1679-91. PubMed ID: 25798618
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Plasticity Drives Adipogenic and Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells.
Meyer MB; Benkusky NA; Sen B; Rubin J; Pike JW
J Biol Chem; 2016 Aug; 291(34):17829-47. PubMed ID: 27402842
[TBL] [Abstract][Full Text] [Related]
18. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program.
Muruganandan S; Roman AA; Sinal CJ
Cell Mol Life Sci; 2009 Jan; 66(2):236-53. PubMed ID: 18854943
[TBL] [Abstract][Full Text] [Related]
19. Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes.
Clabaut A; Delplace S; Chauveau C; Hardouin P; Broux O
Differentiation; 2010 Jul; 80(1):40-5. PubMed ID: 20466479
[TBL] [Abstract][Full Text] [Related]
20. Genetic inhibition of PPARγ S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis.
Ge C; Zhao G; Li B; Li Y; Cawthorn WP; MacDougald OA; Franceschi RT
Bone; 2018 Feb; 107():1-9. PubMed ID: 29107124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
